This article was first published by The Times of Israel and is re-posted with permission.
Israeli scientists are harnessing the “destructive” qualities of allergy-causing cells, as part of a bold attempt to pioneer a new immunotherapy for fighting cancer.
A research team from Tel Aviv University has found that eosinophils, white blood cells that induce allergies, significantly reduce the growth of human tumors in vitro, and mouse tumors in the body.
Nine days after mice were injected with eosinophils, the overall size of tumors per mouse averaged half that of mice who weren’t injected.
To read the full article, click here.